Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple‐Negative Breast Cancer Through Modulating HIF‐1α/MMP‐9 Pathway

Documenti analoghi

• Dynorphin A Inhibits the Proliferation, Migration, Invasion, and Stemness of Triple Negative Breast Cancer Cells
  di: Xiaojiao Liu, et al.
  Pubblicazione: (2026)
• β‐Elemene Suppresses Proliferation, Migration, and Stemness in Triple‐Negative Breast Cancer by Inhibiting SIX‐1
  di: Jia Liu, et al.
  Pubblicazione: (2025)
• Astragaloside IV Enhances Anti‐PD‐L1 Immunotherapy in Triple‐Negative Breast Cancer by Activating the cGAS‐STING Pathway
  di: Chuanchao Wei, et al.
  Pubblicazione: (2026)
• Serum Amyloid A1 Mediates Paclitaxel Resistance via MD2‐Dependent Pathways in Triple‐Negative Breast Cancer
  di: Kangmin Chen, et al.
  Pubblicazione: (2025)
• Skullcapflavone II Suppresses Colorectal Cancer by Inhibiting the HIF ‐1α‐Glycolysis Pathway
  di: Shiwei Yang, et al.
  Pubblicazione: (2025)